The Asia Pacific Capnography Equipment Market is expected to witness market growth of 5.3% CAGR during the forecast period (2022-2028).
There is an increase in the usage of capnography devices over pulse oximetry. The advantages of capnography over oximetry, such as real-time measurement of EtCO2 and quick identification of ventilation, are credited for the rise in demand for capnography equipment. In addition, there are various technical advancements in capnography equipment that make it portable and autonomous.
The increase in the number of people suffering from respiratory disorders is estimated to boost the market growth. Furthermore, the market is predicted to develop as authorities and governments take more measures to strengthen healthcare systems and raise awareness about the benefits of capnography devices.
Growing clinical advantages of capnography equipment over pulse oximetry, rapidly evolving regulations related to the clinical use of capnography, an increasing number of surgeries, accelerating technological advancements, and widespread application of capnometers in hospitals are among the major factors driving the market growth. Furthermore, rising emerging markets and increasing availability of clinical evidence to support capnography monitoring is expected to generate new opportunities for the capnography equipment market in the coming years.
The Asia-Pacific region has the potential to be the largest market for capnography equipment due to the presence of multiple fast-growing economies as well as a huge population. India and China alone account for approximately one-third of the total world population. As the population in these countries grows older, the number of surgeries performed and incidences of pulmonary diseases will grow. Apart from this, there is a rise in government funding for the development of capnography equipment stations, stricter rules that encourage the use of pollution monitoring technology, and technological advancements in the field of environmental sensors.
The rising prevalence of respiratory illnesses is to blame for the growing demand for capnography equipment in the country. The prevalence of asthma in children has increased dramatically in China over the last 20 years. As a result of asthma's debilitating nature, the cost of medical treatment for children with asthma is increasing. Furthermore, according to a report issued by the National Center for Biotechnology Information, lung cancer was the main cause of cancer death in China in 2018, accounting for around 20% of all cancer deaths. Due to these factors, the demand and growth of the regional capnography equipment market is expected to surge in the coming years.
The China market dominated the Asia Pacific Capnography Equipment Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $28,612 Thousands by 2028. The Japan market is estimated to grow at a CAGR of 4.7% during (2022-2028). Additionally, The India market is expected to exhibit a CAGR of 6% during (2022-2028).
Based on Technology, the market is segmented into Mainstream, Sidestream, and Microstream. Based on Application, the market is segmented into Cardiac Care, Trauma & Emergency Care, Respiratory Monitoring, and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers & Home Care, and Others. Based on Product, the market is segmented into Accessories & disposables and Capnometers (Multiparameter and Standalone). Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Masimo Corporation, Koninklijke Philips N.V., Becton, Dickinson and Company, Medtronic PLC, General Electric (GE) Co. (GE Healthcare), Dragerwerk AG & Co. KGaA, Asahi Kasei Corporation (Zoll Medical Corporation), Hamilton Medical AG (Hamilton Bonaduz AG), Edan Instruments, Inc., and Nihon Kohden Corporation.
By Technology
By Country
There is an increase in the usage of capnography devices over pulse oximetry. The advantages of capnography over oximetry, such as real-time measurement of EtCO2 and quick identification of ventilation, are credited for the rise in demand for capnography equipment. In addition, there are various technical advancements in capnography equipment that make it portable and autonomous.
The increase in the number of people suffering from respiratory disorders is estimated to boost the market growth. Furthermore, the market is predicted to develop as authorities and governments take more measures to strengthen healthcare systems and raise awareness about the benefits of capnography devices.
Growing clinical advantages of capnography equipment over pulse oximetry, rapidly evolving regulations related to the clinical use of capnography, an increasing number of surgeries, accelerating technological advancements, and widespread application of capnometers in hospitals are among the major factors driving the market growth. Furthermore, rising emerging markets and increasing availability of clinical evidence to support capnography monitoring is expected to generate new opportunities for the capnography equipment market in the coming years.
The Asia-Pacific region has the potential to be the largest market for capnography equipment due to the presence of multiple fast-growing economies as well as a huge population. India and China alone account for approximately one-third of the total world population. As the population in these countries grows older, the number of surgeries performed and incidences of pulmonary diseases will grow. Apart from this, there is a rise in government funding for the development of capnography equipment stations, stricter rules that encourage the use of pollution monitoring technology, and technological advancements in the field of environmental sensors.
The rising prevalence of respiratory illnesses is to blame for the growing demand for capnography equipment in the country. The prevalence of asthma in children has increased dramatically in China over the last 20 years. As a result of asthma's debilitating nature, the cost of medical treatment for children with asthma is increasing. Furthermore, according to a report issued by the National Center for Biotechnology Information, lung cancer was the main cause of cancer death in China in 2018, accounting for around 20% of all cancer deaths. Due to these factors, the demand and growth of the regional capnography equipment market is expected to surge in the coming years.
The China market dominated the Asia Pacific Capnography Equipment Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $28,612 Thousands by 2028. The Japan market is estimated to grow at a CAGR of 4.7% during (2022-2028). Additionally, The India market is expected to exhibit a CAGR of 6% during (2022-2028).
Based on Technology, the market is segmented into Mainstream, Sidestream, and Microstream. Based on Application, the market is segmented into Cardiac Care, Trauma & Emergency Care, Respiratory Monitoring, and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers & Home Care, and Others. Based on Product, the market is segmented into Accessories & disposables and Capnometers (Multiparameter and Standalone). Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Masimo Corporation, Koninklijke Philips N.V., Becton, Dickinson and Company, Medtronic PLC, General Electric (GE) Co. (GE Healthcare), Dragerwerk AG & Co. KGaA, Asahi Kasei Corporation (Zoll Medical Corporation), Hamilton Medical AG (Hamilton Bonaduz AG), Edan Instruments, Inc., and Nihon Kohden Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- Mainstream
- Sidestream
- Microstream
- Cardiac Care
- Trauma & Emergency Care
- Respiratory Monitoring
- Others
- Hospitals
- Ambulatory Surgery Centers & Home Care
- Others
- Accessories & disposables
- Capnometers
- Multiparameter
- Standalone
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Masimo Corporation
- Koninklijke Philips N.V.
- Becton, Dickinson and Company
- Medtronic PLC
- General Electric (GE) Co. (GE Healthcare)
- Dragerwerk AG & Co. KGaA
- Asahi Kasei Corporation (Zoll Medical Corporation)
- Hamilton Medical AG (Hamilton Bonaduz AG)
- Edan Instruments, Inc.
- Nihon Kohden Corporation
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Capnography Equipment Market by Technology
Chapter 5. Asia Pacific Capnography Equipment Market by Application
Chapter 6. Asia Pacific Capnography Equipment Market by End User
Chapter 7. Asia Pacific Capnography Equipment Market by Product
Chapter 8. Asia Pacific Capnography Equipment Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Masimo Corporation
- Koninklijke Philips N.V.
- Becton, Dickinson and Company
- Medtronic PLC
- General Electric (GE) Co. (GE Healthcare)
- Dragerwerk AG & Co. KGaA
- Asahi Kasei Corporation (Zoll Medical Corporation)
- Hamilton Medical AG (Hamilton Bonaduz AG)
- Edan Instruments, Inc.
- Nihon Kohden Corporation
Methodology
LOADING...